These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4273584)

  • 1. Serum immunoreactive insulin level and tolbutamide concentration in the peripheral blood after a single oral dose of tolbutamide in man.
    Kawanishi K; Goto A; Ishida T
    Acta Med Okayama; 1973 Dec; 27(5):177-83. PubMed ID: 4273584
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoreactive insulin level in the pancreatic vein after the intragastric administration of a single dose of tolbutamide in dogs.
    Kawanishi K; Goto A; Ishida T
    Acta Med Okayama; 1973 Dec; 27(5):185-93. PubMed ID: 4273585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tolbutamide and butylbiguanide on the blood sugar level and level of immunoreductive serum insulin after a glucose infusion in healthy subjects (author's transl)].
    Brodan V; Slabochová Z; Brodanová M; Kuhn E
    Cesk Gastroenterol Vyz; 1975 Mar; 29(2):89-93. PubMed ID: 1131869
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of a rapid intravenous injection of glucose or tolbutamide on plasma-insulin concentration in normal and diabetic subjects.
    Schreuder HB; Schopman W
    Acta Physiol Pharmacol Neerl; 1967 Dec; 14(4):523. PubMed ID: 5582727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative studies of the oral and intravenous tolbutamide test. II. Determination of glucose, serum-insulin and serum-tolbutamide in normal young subjects].
    Berchtold P; Büber V; Meier V; Felber JP; Keiser G
    Diabetologia; 1971 Apr; 7(2):77-81. PubMed ID: 5581543
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the problem of tolbutamide dosage in the oral treatment of diabetes mellitus, simultaneously on the problem of late failure].
    Bruns W; Hildmann W; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):175-80. PubMed ID: 5595283
    [No Abstract]   [Full Text] [Related]  

  • 10. [The dynamics of insulinemia in man after administration of tolbutamide].
    Lenti G; Pellegrini A; Pagano G; Mascia V; Cirillo R
    Minerva Med; 1968 Feb; 59(10):479-87. PubMed ID: 5642230
    [No Abstract]   [Full Text] [Related]  

  • 11. Mild diabetes in young subjects. Clinical aspects and plasma insulin response pattern.
    Johansen K
    Acta Med Scand; 1973; 193(1-2):23-33. PubMed ID: 4705081
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.
    Syvälahti E; Pihlajamäki K; Iisalo E
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):83-9. PubMed ID: 1254383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The insulinemic response after oral administration of glucose and after intravenous administration of tolbutamide in patients with Cushin's syndrome].
    Muggeo M; Tiengo A; Avogaro P; Crepaldi G; Enzi G; Trisotto A; Federspil G
    Acta Isot (Padova); 1967 Dec; 7(1):99-116. PubMed ID: 5612077
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of blood sugar, pyruvate and serum ILA (rat hemidiaphragm) to intravenous sodium tolbutamide in normal and diabetic subjects.
    Rastogi GK
    Indian J Med Res; 1970 Apr; 58(4):438-43. PubMed ID: 5506667
    [No Abstract]   [Full Text] [Related]  

  • 17. [The serum tolbutamide picture during oral treatment of diabetes].
    Leubner H; Saito S
    Wien Klin Wochenschr; 1970 May; 82(18):321-4. PubMed ID: 4930124
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of comparative effectiveness of oral hypoglycaemic agents in single dose in diabetes mellitus.
    Ahuja MM; Kumar V
    J Indian Med Assoc; 1971 Jun; 56(12):366-70. PubMed ID: 5118286
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous glucose tolerance test following oral tolbutamide administration. A possible model for the evaluation of a new hypoglycaemic agent.
    Gadgil SD; Vaidya AB; Rajagopalan TG; Talwalkar PK; Desai ND; Gupta S; Paul T; Satoskar RS; Bhandarkar SD
    J Postgrad Med; 1983 Apr; 29(2):82-8. PubMed ID: 6631767
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen.
    Vinik AI; Jackson WP; Keller P; Marine N
    Diabetologia; 1968 Aug; 4(4):203-9. PubMed ID: 5738360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.